Hp--CD-Voriconazole In Situ Gelling System for Ocular Drug Delivery: In Vitro , Stability, and Antifungal Activities Assessment
The objective of the present study was to design ophthalmic delivery systems based on polymeric carriers that undergo sol-to-gel transition upon change in temperature or in the presence of cations so as to prolong the effect of HP- β -CD Voriconazole (VCZ) in situ gelling formulations. The in situ g...
Gespeichert in:
Veröffentlicht in: | BioMed research international 2013, Vol.2013, p.1-9 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The objective of the present study was to design ophthalmic delivery systems based on polymeric carriers that undergo sol-to-gel transition upon change in temperature or in the presence of cations so as to prolong the effect of HP-
β
-CD Voriconazole (VCZ)
in situ
gelling formulations. The
in situ
gelling formulations of Voriconazole were prepared by using pluronic F-127 (PF-127) or with combination of pluronic F-68 (PF-68) and sodium alginate by cold method technique. The prepared formulations were evaluated for their physical appearance, drug content, gelation temperature (),
in vitro
permeation studies, rheological properties, mucoadhesion studies, antifungal studies, and stability studies. All batches of
in situ
formulations had satisfactory pH ranging from 6.8 to 7.4, drug content between 95% and 100%, showing uniform distribution of drug. As the concentration of each polymeric component was increased, that is, PF-68 and sodium alginate, there was a decrease in with increase in viscosity and mucoadhesive strength. The
in vitro
drug release decreased with increase in polymeric concentrations. The stability data concluded that all formulations showed the low degradation and maximum shelf life of 2 years. The antifungal efficiency of the selected formulation against
Candida albicans
and
Asperigillus fumigatus
confirmed that designed formulation has prolonged effect and retained its properties against fungal infection. |
---|---|
ISSN: | 2314-6133 2314-6141 |
DOI: | 10.1155/2013/341218 |